Zydus gets USFDA nod for antiviral drug used in HIV treatment

Zydus Lifesciences obtained final clearance from the USFDA for Darunavir Tablets, an antiviral medication used in treating HIV-1 infection. Darunavir, a protease inhibitor, restricts HIV-1 multiplication and is prescribed for adults and pediatric patients over three years old. Co-administration with Ritonavir and other antiretroviral agents is necessary. Manufactured in Ahmedabad, Gujarat, the medication holds significant market potential, recording USD 275 million in annual US sales.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news